|
Primary prevention
Citations 231-240 of 558 total displayed.
|
Past content
(since Feb 1999):
|
- AHA Scientific Statements
Diagnosis and Management of the Metabolic Syndrome: An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement: Executive Summary
- Scott M. Grundy, James I. Cleeman, Stephen R. Daniels, Karen A. Donato, Robert H. Eckel, Barry A. Franklin, David J. Gordon, Ronald M. Krauss, Peter J. Savage, Sidney C. Smith, Jr, John A. Spertus, and Fernando Costa
Circulation 2005;112:e285-290e; published online before print as doi:10.1161/CIRCULATIONAHA.105.169405
[Full text]
- AHA/NHLBI Scientific Statement
Diagnosis and Management of the Metabolic Syndrome: An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement
- Scott M. Grundy, James I. Cleeman, Stephen R. Daniels, Karen A. Donato, Robert H. Eckel, Barry A. Franklin, David J. Gordon, Ronald M. Krauss, Peter J. Savage, Sidney C. Smith, Jr, John A. Spertus, and Fernando Costa
Circulation 2005;112:2735-2752; published online before print as doi:10.1161/CIRCULATIONAHA.105.169404
[Full text]
- AHA Scientific Statements
Taking the Initiative: Implementing the American Heart Association Guide for Improving Cardiovascular Health at the Community Level: Healthy People 2010 Heart Disease and Stroke Partnership Community Guideline Implementation and Best Practices Workgroup
- Mark A. Veazie, James M. Galloway, Dyann Matson-Koffman, Darwin R. LaBarthe, J. Nell Brownstein, Marian Emr, Eric Bolton, Eugene Freund, Jr, Robinson Fulwood, Jeanette Guyton-Krishnan, Yuling Hong, Michael Lebowitz, Emmeline Ochiai, Mark Schoeberl, and Rose Marie Robertson
Circulation 2005;112:2538-2554, doi:10.1161/CIRCULATIONAHA.105.169179
[Full text]
- Epidemiology
 -Glutamyltransferase as a Risk Factor for Cardiovascular Disease Mortality: An Epidemiological Investigation in a Cohort of 163 944 Austrian Adults
- Elfriede Ruttmann, Larry J. Brant, Hans Concin, Günter Diem, Kilian Rapp, Hanno Ulmer, and the Vorarlberg Health Monitoring and Promotion Program Study Group
Circulation 2005;112:2130-2137; published online before print as doi:10.1161/CIRCULATIONAHA.105.552547
[Abstract]
[Full text]
- Pericardial Disease
Colchicine in Addition to Conventional Therapy for Acute Pericarditis: Results of the COlchicine for acute PEricarditis (COPE) Trial
- Massimo Imazio, Marco Bobbio, Enrico Cecchi, Daniela Demarie, Brunella Demichelis, Franco Pomari, Mauro Moratti, Gianni Gaschino, Massimo Giammaria, Aldo Ghisio, Riccardo Belli, and Rita Trinchero
Circulation 2005;112:2012-2016, doi:10.1161/CIRCULATIONAHA.105.542738
[Abstract]
[Full text]
- Articles
-Glutamyltransferase as a Risk Factor for Cardiovascular Disease Mortality. An Epidemiological Investigation in a Cohort of 163 944 Austrian Adults
- Elfriede Ruttmann, Larry J. Brant, Hans Concin, Günter Diem, Kilian Rapp, Hanno Ulmer and the Vorarlberg Health Monitoring and Promotion Program Study Group
Circulation published September 26, 2005, doi:10.1161/CIRCULATIONAHA.105.552547
[Abstract]
- Articles
Diagnosis and Management of the Metabolic Syndrome. An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Executive Summary
- Scott M. Grundy, James I. Cleeman, Stephen R. Daniels, Karen A. Donato, Robert H. Eckel, Barry A. Franklin, David J. Gordon, Ronald M. Krauss, Peter J. Savage, Sidney C. Smith, Jr, John A. Spertus, and Fernando Costa
Circulation published September 12, 2005, doi:10.1161/CIRCULATIONAHA.105.169405
[Abstract]
- Articles
Diagnosis and Management of the Metabolic Syndrome. An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement
- Scott M. Grundy, James I. Cleeman, Stephen R. Daniels, Karen A. Donato, Robert H. Eckel, Barry A. Franklin, David J. Gordon, Ronald M. Krauss, Peter J. Savage, Sidney C. Smith, Jr, John A. Spertus, and Fernando Costa
Circulation published September 12, 2005, doi:10.1161/CIRCULATIONAHA.105.169404
[Abstract]
- Clinician Update
Diuretics for Hypertension
- Lawrence R. Krakoff
Circulation 2005;112:e127-129e, doi:10.1161/CIRCULATIONAHA.105.570192
[Full text]
- Health Services and Outcomes Research
Impact of the Pravastatin or Atorvastatin Evaluation and Infection Therapy–Thrombolysis In Myocardial Infarction 22/Reversal of Atherosclerosis With Aggressive Lipid Lowering Trials on Trends in Intensive Versus Moderate Statin Therapy in Ontario, Canada
- Peter C. Austin and Muhammad M. Mamdani
Circulation 2005;112:1296-1300; published online before print as doi:10.1161/CIRCULATIONAHA.104.531582
[Abstract]
[Full text]
|
|
